Results 11 to 20 of about 5,985 (143)

Evaluating the effectiveness and cost-effectiveness of integrating mass drug administration for helminth control with seasonal malaria chemoprevention in Ghanaian children: Protocol for a cluster randomised controlled trial. [PDF]

Trop Med Int Health
To evaluate the effectiveness and cost‐effectiveness of integrating seasonal malaria chemoprevention (SMC) with mass drug administration for helminth control among school‐aged children living in communities where the burden of malaria and helminths is ...
Afolabi MO, Adu-Gyasi D, Paintain L, Tawiah T, Ali MS, Greenwood B, Asante KP.   +6 more
europepmc   +4 more sources

Assessing the Acceptability and Feasibility of Five Cycles of Seasonal Malaria Chemoprevention in Côte d'Ivoire. [PDF]

Trop Med Infect Dis
Seasonal malaria chemoprevention (SMC) is a strategy recommended by the World Health Organization for children aged 3–59 months in the Sahel and sub-Sahel regions where malaria transmission is seasonal.
Kangah O, Zongo I, Haro A, Yavo W.
europepmc   +6 more sources

Impact of seasonal malaria chemoprevention timing on clinical malaria incidence dynamics in the Kedougou region, Senegal. [PDF]

PLOS Glob Public Health
Seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine and amodiaquine is recommended by the World Health Organization since 2012 for clinical malaria prevention in children in the Sahelian region of Africa.
Kazanga B, Ba EH, Legendre E, Cissoko M, Fleury L, Bérard L, Diop A, Sokhna C, Danfakha F, Sagara I, Ndiaye JL, Gaudart J, Landier J.   +12 more
europepmc   +5 more sources

Dihydroartemisinin-piperaquine effectiveness for seasonal malaria chemoprevention in settings with extended seasonal malaria transmission in Tanzania. [PDF]

Sci Rep
Effectiveness of dihydroartemisinin-piperaquine (DP) as seasonal malaria chemoprevention (SMC) was assessed in Nanyumbu and Masasi Districts. Between March and June 2021, children aged 3–59 months were enrolled in a cluster randomized study.
Mwaiswelo R, Ngasala B, Chaky F, Molteni F, Mohamed A, Lazaro S, Samwel B, Mmbando BP.   +7 more
europepmc   +7 more sources

Household-level effects of seasonal malaria chemoprevention in the Gambia. [PDF]

Commun Med (Lond), 2023
Background In 2022 the WHO recommended the discretionary expansion of the eligible age range for seasonal malaria chemoprevention (SMC) to children older than 4 years.
Soremekun S, Conteh B, Nyassi A, Soumare HM, Etoketim B, Ndiath MO, Bradley J, D'Alessandro U, Bousema T, Erhart A, Moreno M, Drakeley C.   +11 more
europepmc   +6 more sources

Systematic Review and Meta-Analysis of Seasonal Malaria Chemoprevention. [PDF]

Am J Trop Med Hyg, 2023
. Seasonal malaria chemoprevention (SMC) for children under 5 years of age for up to four monthly cycles during malaria transmission season was recommended by the WHO in 2012 and has been implemented in 13 countries in the Sahel, reaching more than 30 ...
Thwing J, Williamson J, Cavros I, Gutman JR.   +3 more
europepmc   +4 more sources

Systematic review on the cost of seasonal malaria chemoprevention (SMC). [PDF]

Malar J
Background Implemented in 17 countries to date, seasonal malaria chemoprevention (SMC) is a recommended strategy to prevent childhood malaria in areas with seasonal transmission of P.
Ruisch A, Iodice M, Mathur I, Harris S, Walker DG, Owusu R, Nonvignon J, Gilmartin C.   +7 more
europepmc   +5 more sources

Effect of seasonal malaria chemoprevention on incidence of malaria among children under five years in Kotido and Moroto Districts, Uganda, 2021: time series analysis. [PDF]

Malar J
Background Seasonal malaria chemoprevention (SMC) refers to monthly administration of full treatment courses of anti-malarial medicine to children
Kwiringira A, Kwesiga B, Migisha R, Bulage L, Kadobera D, Rutazaana D, Harris JR, Ario AR, Ssempiira J.   +8 more
europepmc   +3 more sources

Asymptomatic Plasmodium falciparum infections and determinants of carriage in a seasonal malaria chemoprevention setting in Northern Cameroon and south Senegal (Kedougou). [PDF]

Malar J
Background Among the several strategies recommended for the fight against malaria, seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine and amodiaquine combination (SPAQ) targets children 3 months to 5 years in Sahel regions of Africa to
Ali IM, Manga IA, Nji AM, Tchuenkam VP, Neba PTN, Achu DF, Bigoga JD, Faye B, Roper C, Sutherland CJ, Mbacham WF.   +10 more
europepmc   +3 more sources

Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention. [PDF]

New England Journal of Medicine, 2021
Malaria control remains a challenge in many parts of the Sahel and sub-Sahel regions of Africa.We conducted an individually randomized, controlled trial to assess whether seasonal vaccination with RTS,S/AS01E was noninferior to chemoprevention in preventing uncomplicated malaria and whether the two interventions combined were superior to either one ...
D. Chandramohan, I. Zongo, I. Sagara, M. Cairns, R. Yerbanga, M. Diarra, Frederic Nikiema, A. Tapily, Frédéric Sompougdou, Djibrilla Issiaka, Charles Zoungrana, K. Sanogo, A. Haro, Mahamadou Kaya, Abdoul-Aziz Sienou, S. Traoré, A. Mahamar, Ismaila Théra, Kalifa Diarra, A. Dolo, Irene Kuepfer, Paul C Snell, P. Milligan, C. Ockenhouse, O. Ofori-Anyinam, H. Tinto, A. Djimde, J. Ouédraogo, A. Dicko, B. Greenwood   +29 more
semanticscholar   +6 more sources